Aztreonam Trials Reveal Modest Clinical Benefit for Patients with Non-cystic Fibrosis Bronchiectasis
News
Results from two randomized, placebo-controlled phase 3 trials on the efficacy of inhaled Aztreonam for patients with non-cystic fibrosis bronchiectasis showed that the drug does not offer significant clinical benefit. The study published in The ... Read more